The Centers for Disease Control and Prevention is aggressively becoming hands-on in the prevention of type 2 diabetes. A new national diabetes prevention program is under way under the tutelage of previous successful clinical research and trials results. What can healthcare professionals treating patients with diabetes learn and how can they get involved? Join host Dr. Steven Edelman and his guest, the director of the division of diabetes translation at the Centers for Disease Control and Prevention, Dr. Ann Albright, as they discuss the criteria for the National Diabetes Prevention Program.
The Centers for Disease Control’s Approach to Prevention of Diabetes

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
The Centers for Disease Control and Prevention is aggressively becoming hands-on in the prevention of type 2 diabetes. A new national diabetes prevention program is under way under the tutelage of previous successful clinical research and trials results. What can healthcare professionals treating patients with diabetes learn and how can they get involved? Join host Dr. Steven Edelman and his guest, the director of the division of diabetes translation at the Centers for Disease Control and Prevention, Dr. Ann Albright, as they discuss the criteria for the National Diabetes Prevention Program.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Chemotherapy Strategies for Metastatic PDAC
Partnering with Patients: Building Effective Communication and Support in HF Care
A Practical Guide to Prescribing in HF
Clinical Conundrums in ARIA: Nuances of Microhemorrhages when Evaluating an MRI for ARIA
Clinical Conundrums in ARIA: Differential Diagnoses and Potential Pitfalls in ARIA Evaluation
Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?